CN113694117A - Preparation process of traditional Chinese medicine extract for treating prostate - Google Patents
Preparation process of traditional Chinese medicine extract for treating prostate Download PDFInfo
- Publication number
- CN113694117A CN113694117A CN202111200188.0A CN202111200188A CN113694117A CN 113694117 A CN113694117 A CN 113694117A CN 202111200188 A CN202111200188 A CN 202111200188A CN 113694117 A CN113694117 A CN 113694117A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- raw materials
- medicine extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 210000002307 prostate Anatomy 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 35
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 23
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 20
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 20
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 20
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 19
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 19
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 19
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 19
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 19
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 19
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 19
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 19
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 19
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 19
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 19
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 19
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 19
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 19
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 18
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 18
- 240000000233 Melia azedarach Species 0.000 claims abstract description 18
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 16
- 244000148137 Patrinia villosa Species 0.000 claims abstract description 10
- 235000019109 Patrinia villosa Nutrition 0.000 claims abstract description 10
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 5
- 241000245665 Taraxacum Species 0.000 claims description 17
- 239000011521 glass Substances 0.000 claims description 15
- 238000004140 cleaning Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005086 pumping Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 201000007094 prostatitis Diseases 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000027939 micturition Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 206010013990 dysuria Diseases 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 210000002149 gonad Anatomy 0.000 abstract description 2
- 241000736199 Paeonia Species 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 206010000269 abscess Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 229940124350 antibacterial drug Drugs 0.000 description 2
- 208000013507 chronic prostatitis Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010005052 Bladder irritation Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000219321 Caryophyllaceae Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 235000012511 Vaccinium Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 1
- 229960001668 cefuroxime Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation process of a traditional Chinese medicine extract for treating prostate gland, which is prepared from the following main raw materials in parts by weight: 8-13 parts of salvia miltiorrhiza, 7-12 parts of herba lycopi, 6-11 parts of red peony root, 9-13 parts of peach kernel, 2-6 parts of safflower, 2-6 parts of frankincense, 4-8 parts of myrrh, 7-12 parts of cowherb seed, 4-8 parts of green tangerine peel, 6-10 parts of szechwan chinaberry fruit, 4-8 parts of fennel, 8-12 parts of angelica dahurica, 18-22 parts of dahurian patrinia herb and 19-24 parts of dandelion. Compared with the prior art, the invention has the advantages that: can effectively improve prostatitis, prostatauxe and symptoms caused by the prostatitis and the prostatauxe, such as frequent micturition, dysuria, anuresis, white drip, and the like, and also has the health-care function of enhancing the resistance of the gonad.
Description
Technical Field
The invention relates to the technical field of prostate treatment, in particular to a preparation process of a traditional Chinese medicine extract for treating prostate.
Background
Prostatitis is a common frequently-encountered disease of middle-aged and elderly people, and is caused by the invasion of pathogenic microorganisms to cause the prostate to form an inflammatory reaction. If the treatment cannot be timely and effectively carried out, chronic prostatitis develops, and symptoms such as incomplete urine, urine retention, urine waiting, difficult urination and the like appear. The current clinical treatment situations are as follows: 1. patients with acute prostatitis should be treated by lying in bed, drinking more water, relaxing bowels and the like. Patients with severe bladder irritation symptoms can be administered analgesic and spasmolytic medicine and hot water hip bath to relieve symptoms. The antibacterial agent can be selected from penicillin, streptomycin, ampicillin, cephalosporin and cefuroxime. After general symptomatic treatment and anti-inflammatory treatment, the symptoms of acute prostatitis usually disappear within 1-2 weeks. If the symptoms are not good or aggravated, palpation of the prostate and anus is more swollen and fluctuated, abscess is formed in B-ultrasonic examination, and abscess is extracted by perineal puncture and is incised to drain the abscess through perineum. 2. The chronic prostatitis mainly adopts the following measures: prostate massage, drug perfusion, urethral dilation, prostate peri-sealing, and antibacterial drugs. The treatment methods have certain side effects, long treatment period and unstable curative effect, and common antibacterial drugs are not easy to enter prostate tissues, which is one of the reasons for difficult clinical treatment.
Disclosure of Invention
The invention aims to solve the technical problem of overcoming the technical defects and provides a preparation process of a traditional Chinese medicine extract for treating prostate.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: a traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 8-13 parts of salvia miltiorrhiza, 7-12 parts of herba lycopi, 6-11 parts of red peony root, 9-13 parts of peach kernel, 2-6 parts of safflower, 2-6 parts of frankincense, 4-8 parts of myrrh, 7-12 parts of cowherb seed, 4-8 parts of green tangerine peel, 6-10 parts of szechwan chinaberry fruit, 4-8 parts of fennel, 8-12 parts of angelica dahurica, 18-22 parts of dahurian patrinia herb and 19-24 parts of dandelion.
As an improvement, the traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10-11 parts of salvia miltiorrhiza, 8-11 parts of herba lycopi, 7-10 parts of red peony root, 10-12 parts of peach kernel, 3-5 parts of safflower, 3-5 parts of frankincense, 5-7 parts of myrrh, 8-11 parts of cowherb seed, 5-7 parts of green tangerine peel, 7-9 parts of szechwan chinaberry fruit, 5-7 parts of fennel, 9-11 parts of angelica dahurica, 19-21 parts of herba patriniae and 20-23 parts of dandelion.
As an improvement, the traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10 parts of salvia miltiorrhiza, 10 parts of herba lycopi, 9 parts of red peony root, 11 parts of peach kernel, 4.5 parts of safflower, 4.5 parts of frankincense, 5.5 parts of myrrh, 10 parts of cowherb seed, 6 parts of green tangerine peel, 6 parts of szechwan chinaberry fruit, 3 parts of common fennel fruit, 6 parts of angelica dahurica, 20 parts of herba patriniae and 21 parts of dandelion.
A preparation method of a traditional Chinese medicine extract for treating prostate comprises the following steps:
(1) cleaning the salvia miltiorrhiza, the herba lycopi, the red peony root, the peach kernel, the safflower, the frankincense, the myrrh, the cowherb seed, the green tangerine peel, the szechwan chinaberry fruit, the fennel, the angelica dahurica, the patrinia herb and the dandelion respectively, drying, grinding and screening for later use;
(2) weighing the dried and crushed raw materials in the step (1) according to the formula ratio, placing the raw materials in a traditional Chinese medicine extraction tank, adding water to soak the raw materials for decoction, pumping the decoction into a concentration tank for concentration under reduced pressure, and collecting concentrated solution;
(3) heating the concentrated solution in the step (2) to boil, adding honey, mixing and homogenizing;
(4) and (4) filtering the mixed and homogenized concentrated solution obtained in the step (3), subpackaging the filtered and homogenized concentrated solution in a glass bottle after cleaning and sterilization, and covering the glass bottle for later use.
As an improvement, in the step (2), all the raw materials are placed in a traditional Chinese medicine extraction tank for decoction for 1-2 hours.
As an improvement, the glass bottle in the step (6) is sterilized by high-temperature steam.
Compared with the prior art, the invention has the advantages that: the traditional Chinese medicine composition for treating prostatitis disclosed by the invention is based on the principle of treating prostatitis by traditional Chinese medicines, can effectively improve prostatitis and prostatic hyperplasia and symptoms caused by the prostatitis and the prostatic hyperplasia, such as frequent micturition, dysuria, anuresis, white drops and the like, and also has a health-care effect of enhancing the resistance of gonads. Meanwhile, the medicine has the functions of tonifying the kidney, controlling nocturnal emission, separating clear, guiding turbid, dispersing blood stasis and promoting diuresis and the functions of medicinal moxibustion, namely dispelling cold from wet channels, eliminating stasis, dissipating binds, drawing out toxin and discharging heat, can be synchronously carried out, and has strong pertinence and good effect of treating prostatitis.
Detailed Description
The raw materials used in the formula of the invention all adopt common Chinese herbal medicines, and the medicine source is rich and easy to obtain. The attributes and effects of the Chinese herbal medicine raw materials in the formula are as follows:
red sage root: the product is dried root and rhizome of Salvia miltiorrhiza Bunge of Labiatae. Bitter taste and slightly cold nature; heart and liver meridian entered; dispel stasis and alleviate pain, activate blood and dredge meridians, clear heart fire and relieve restlessness.
Herba lycopi: promoting blood circulation, dispelling blood stasis, inducing diuresis, and relieving swelling. Modern pharmaceutical research proves that the herba lycopi contains volatile oil, flavonoid glycoside, saponin, phenols, saccharides and tannin. Has antitumor, insecticidal, SARS virus resisting, and antibacterial effects.
Red peony root: is dried root of Ranunculaceae plant radix Paeoniae Rubra or radix Paeoniae Rubra. Collected in spring and autumn, removed rhizome, fibrous root and silt, and dried in the sun. Bitter and slightly cold. It enters liver meridian. Has the effects of clearing heat, cooling blood, promoting blood circulation and removing blood stasis.
Peach kernel: the product is dried mature seed of Prunus persica or Prunus davidiana of Rosaceae. Bitter and sweet in taste and mild in nature; the heart, liver and large intestine meridians entered; promote blood circulation to remove blood stasis, moisten intestines to relieve constipation.
Safflower: promoting blood circulation, dredging channels, removing blood stasis and relieving pain. Modern pharmaceutical research proves that the safflower contains safflower yellow and has good functions of anticoagulation, fatigue resistance, inflammation resistance and immunity improvement.
Frankincense: being pungent, bitter and warm in nature, entering heart, liver and spleen meridians, regulating qi, activating blood, relieving pain and removing toxic substance.
Myrrh: bitter and neutral in nature and flavor, entering liver meridian, dissipating blood stasis, relieving swelling and alleviating pain.
Seed of cowherb: is dried mature seed of Vaccinium arvense of Caryophyllaceae; bitter in nature and mild in taste; meridian tropism entering liver and stomach meridians; the functions are mainly used for promoting blood circulation and stimulating the menstrual flow, and promoting lactation and relieving swelling; can be used for treating galactostasis, amenorrhea, dysmenorrhea, and swelling and pain due to acute mastitis;
green tangerine peel: bitter, pungent and warm. It enters liver, gallbladder and stomach meridians. To soothe the liver, break qi, resolve stagnation and resolve stagnation. It can be used for treating hypochondriac pain, breast pain, gastralgia, breast tuberculosis, acute mastitis, hernia, dyspepsia, abdominal mass, and chronic malaria
Toosendan fruit: bitter, cold and slightly toxic. It enters liver, stomach and small intestine meridians. To soothe the liver, release heat, promote qi circulation, alleviate pain and kill parasites. It can be used for treating abdominal pain, hernia pain, abdominal pain due to parasitic infestation, and tinea capitis.
Fennel: the fennel has pungent taste and warm nature, has the effects of dispelling cold, relieving pain, harmonizing stomach and regulating qi, and has the effects of warming middle-jiao and relieving pain.
Radix angelicae: expelling wind, relieving exterior syndrome, expelling cold, alleviating pain, removing dampness, dredging orifices, and relieving swelling and pus. Modern pharmaceutical research proves that the angelica dahurica has the effects of relieving fever, easing pain, resisting inflammation, resisting bacteria and the like.
Herba Patriniae: the effective herba patriniae is prepared from rhizome, root and whole herb, belongs to heat-clearing and detoxifying herbs in traditional Chinese medicines, and is cool in nature, pungent and bitter in taste. It enters liver, stomach and large intestine meridians and has the functions of clearing away heat and toxic material, dispelling blood stasis and expelling pus.
Dandelion: bitter and sweet in flavor, cold in nature, entering liver and stomach meridians. For mammary abscess, the essential herbs can resolve depression, remove heat-toxin, purge damp-heat, disperse stagnation of qi, unblock collaterals and resolve carbuncle and swelling. It is mild in nature, bitter in flavor but without damaging the body resistance, and clear heat but without damaging stomach yin.
Example 1
A traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 8-13 parts of salvia miltiorrhiza, 7-12 parts of herba lycopi, 6-11 parts of red peony root, 9-13 parts of peach kernel, 2-6 parts of safflower, 2-6 parts of frankincense, 4-8 parts of myrrh, 7-12 parts of cowherb seed, 4-8 parts of green tangerine peel, 6-10 parts of szechwan chinaberry fruit, 4-8 parts of fennel, 8-12 parts of angelica dahurica, 18-22 parts of dahurian patrinia herb and 19-24 parts of dandelion.
A preparation method of a traditional Chinese medicine extract for treating prostate comprises the following steps:
(1) cleaning the salvia miltiorrhiza, the herba lycopi, the red peony root, the peach kernel, the safflower, the frankincense, the myrrh, the cowherb seed, the green tangerine peel, the szechwan chinaberry fruit, the fennel, the angelica dahurica, the patrinia herb and the dandelion respectively, drying, grinding and screening for later use;
(2) weighing the dried and crushed raw materials in the step (1) according to the formula ratio, placing the raw materials in a traditional Chinese medicine extraction tank, adding water to soak the raw materials for decoction, pumping the decoction into a concentration tank for concentration under reduced pressure, and collecting concentrated solution;
(3) heating the concentrated solution in the step (2) to boil, adding honey, mixing and homogenizing;
(4) and (4) filtering the mixed and homogenized concentrated solution obtained in the step (3), subpackaging the filtered and homogenized concentrated solution in a glass bottle after cleaning and sterilization, and covering the glass bottle for later use.
And (3) putting the raw materials in the step (2) into a traditional Chinese medicine extraction tank, and decocting for 1-2 h.
And (4) sterilizing the glass bottle in the step (6) by adopting high-temperature steam.
Example 2
A traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10-11 parts of salvia miltiorrhiza, 8-11 parts of herba lycopi, 7-10 parts of red peony root, 10-12 parts of peach kernel, 3-5 parts of safflower, 3-5 parts of frankincense, 5-7 parts of myrrh, 8-11 parts of cowherb seed, 5-7 parts of green tangerine peel, 7-9 parts of szechwan chinaberry fruit, 5-7 parts of fennel, 9-11 parts of angelica dahurica, 19-21 parts of herba patriniae and 20-23 parts of dandelion.
A traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10 parts of salvia miltiorrhiza, 10 parts of herba lycopi, 9 parts of red peony root, 11 parts of peach kernel, 4.5 parts of safflower, 4.5 parts of frankincense, 5.5 parts of myrrh, 10 parts of cowherb seed, 6 parts of green tangerine peel, 6 parts of szechwan chinaberry fruit, 3 parts of common fennel fruit, 6 parts of angelica dahurica, 20 parts of herba patriniae and 21 parts of dandelion.
A preparation method of a traditional Chinese medicine extract for treating prostate comprises the following steps:
(1) cleaning the salvia miltiorrhiza, the herba lycopi, the red peony root, the peach kernel, the safflower, the frankincense, the myrrh, the cowherb seed, the green tangerine peel, the szechwan chinaberry fruit, the fennel, the angelica dahurica, the patrinia herb and the dandelion respectively, drying, grinding and screening for later use;
(2) weighing the dried and crushed raw materials in the step (1) according to the formula ratio, placing the raw materials in a traditional Chinese medicine extraction tank, adding water to soak the raw materials for decoction, pumping the decoction into a concentration tank for concentration under reduced pressure, and collecting concentrated solution;
(3) heating the concentrated solution in the step (2) to boil, adding honey, mixing and homogenizing;
(4) and (4) filtering the mixed and homogenized concentrated solution obtained in the step (3), subpackaging the filtered and homogenized concentrated solution in a glass bottle after cleaning and sterilization, and covering the glass bottle for later use.
And (3) putting the raw materials in the step (2) into a traditional Chinese medicine extraction tank, and decocting for 1-2 h.
And (4) sterilizing the glass bottle in the step (6) by adopting high-temperature steam.
Example 3
A traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 8-13 parts of salvia miltiorrhiza, 7-12 parts of herba lycopi, 6-11 parts of red peony root, 9-13 parts of peach kernel, 2-6 parts of safflower, 2-6 parts of frankincense, 4-8 parts of myrrh, 7-12 parts of cowherb seed, 4-8 parts of green tangerine peel, 6-10 parts of szechwan chinaberry fruit, 4-8 parts of fennel, 8-12 parts of angelica dahurica, 18-22 parts of dahurian patrinia herb and 19-24 parts of dandelion.
As an improvement, the traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10-11 parts of salvia miltiorrhiza, 8-11 parts of herba lycopi, 7-10 parts of red peony root, 10-12 parts of peach kernel, 3-5 parts of safflower, 3-5 parts of frankincense, 5-7 parts of myrrh, 8-11 parts of cowherb seed, 5-7 parts of green tangerine peel, 7-9 parts of szechwan chinaberry fruit, 5-7 parts of fennel, 9-11 parts of angelica dahurica, 19-21 parts of herba patriniae and 20-23 parts of dandelion.
As an improvement, the traditional Chinese medicine extract for treating prostate is prepared from the following main raw materials in parts by weight: 10 parts of salvia miltiorrhiza, 10 parts of herba lycopi, 9 parts of red peony root, 11 parts of peach kernel, 4.5 parts of safflower, 4.5 parts of frankincense, 5.5 parts of myrrh, 10 parts of cowherb seed, 6 parts of green tangerine peel, 6 parts of szechwan chinaberry fruit, 3 parts of common fennel fruit, 6 parts of angelica dahurica, 20 parts of herba patriniae and 21 parts of dandelion.
A preparation method of a traditional Chinese medicine extract for treating prostate comprises the following steps:
(1) cleaning the salvia miltiorrhiza, the herba lycopi, the red peony root, the peach kernel, the safflower, the frankincense, the myrrh, the cowherb seed, the green tangerine peel, the szechwan chinaberry fruit, the fennel, the angelica dahurica, the patrinia herb and the dandelion respectively, drying, grinding and screening for later use;
(2) weighing the dried and crushed raw materials in the step (1) according to the formula ratio, placing the raw materials in a traditional Chinese medicine extraction tank, adding water to soak the raw materials for decoction, pumping the decoction into a concentration tank for concentration under reduced pressure, and collecting concentrated solution;
(3) heating the concentrated solution in the step (2) to boil, adding honey, mixing and homogenizing;
(4) and (4) filtering the mixed and homogenized concentrated solution obtained in the step (3), subpackaging the filtered and homogenized concentrated solution in a glass bottle after cleaning and sterilization, and covering the glass bottle for later use.
And (3) putting the raw materials in the step (2) into a traditional Chinese medicine extraction tank, and decocting for 1-2 h.
And (4) sterilizing the glass bottle in the step (6) by adopting high-temperature steam.
The present invention and the embodiments thereof have been described above without limitation, and it is within the scope of the present invention that those skilled in the art should be able to devise similar structural modes and embodiments without inventive changes without departing from the spirit and scope of the present invention.
Claims (6)
1. The traditional Chinese medicine extract for treating prostate is characterized by being prepared from the following main raw materials in parts by weight: 8-13 parts of salvia miltiorrhiza, 7-12 parts of herba lycopi, 6-11 parts of red peony root, 9-13 parts of peach kernel, 2-6 parts of safflower, 2-6 parts of frankincense, 4-8 parts of myrrh, 7-12 parts of cowherb seed, 4-8 parts of green tangerine peel, 6-10 parts of szechwan chinaberry fruit, 4-8 parts of fennel, 8-12 parts of angelica dahurica, 18-22 parts of dahurian patrinia herb and 19-24 parts of dandelion.
2. The traditional Chinese medicine extract for treating prostate as claimed in claim 1, which is prepared from the following main raw materials in parts by weight: 10-11 parts of salvia miltiorrhiza, 8-11 parts of herba lycopi, 7-10 parts of red peony root, 10-12 parts of peach kernel, 3-5 parts of safflower, 3-5 parts of frankincense, 5-7 parts of myrrh, 8-11 parts of cowherb seed, 5-7 parts of green tangerine peel, 7-9 parts of szechwan chinaberry fruit, 5-7 parts of fennel, 9-11 parts of angelica dahurica, 19-21 parts of herba patriniae and 20-23 parts of dandelion.
3. The traditional Chinese medicine extract for treating prostate as claimed in claim 1, which is prepared from the following main raw materials in parts by weight: 10 parts of salvia miltiorrhiza, 10 parts of herba lycopi, 9 parts of red peony root, 11 parts of peach kernel, 4.5 parts of safflower, 4.5 parts of frankincense, 5.5 parts of myrrh, 10 parts of cowherb seed, 6 parts of green tangerine peel, 6 parts of szechwan chinaberry fruit, 3 parts of common fennel fruit, 6 parts of angelica dahurica, 20 parts of herba patriniae and 21 parts of dandelion.
4. The preparation method of the traditional Chinese medicine extract for treating prostate as claimed in any one of claims 1-3, characterized by comprising the following steps:
(1) cleaning the salvia miltiorrhiza, the herba lycopi, the red peony root, the peach kernel, the safflower, the frankincense, the myrrh, the cowherb seed, the green tangerine peel, the szechwan chinaberry fruit, the fennel, the angelica dahurica, the patrinia herb and the dandelion respectively, drying, grinding and screening for later use;
(2) weighing the dried and crushed raw materials in the step (1) according to the formula ratio, placing the raw materials in a traditional Chinese medicine extraction tank, adding water to soak the raw materials for decoction, pumping the decoction into a concentration tank for concentration under reduced pressure, and collecting concentrated solution;
(3) heating the concentrated solution in the step (2) to boil, adding honey, mixing and homogenizing;
(4) and (4) filtering the mixed and homogenized concentrated solution obtained in the step (3), subpackaging the filtered and homogenized concentrated solution in a glass bottle after cleaning and sterilization, and covering the glass bottle for later use.
5. The preparation method of the traditional Chinese medicine extract for treating prostate as claimed in claim 4, wherein in the step (2), each raw material is placed in a traditional Chinese medicine extraction tank to be decocted for 1-2 h.
6. The method for preparing the traditional Chinese medicine extract for treating prostate as claimed in claim 4, wherein the glass bottle in the step (6) is sterilized by high temperature steam.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111200188.0A CN113694117A (en) | 2021-10-14 | 2021-10-14 | Preparation process of traditional Chinese medicine extract for treating prostate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111200188.0A CN113694117A (en) | 2021-10-14 | 2021-10-14 | Preparation process of traditional Chinese medicine extract for treating prostate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113694117A true CN113694117A (en) | 2021-11-26 |
Family
ID=78662790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111200188.0A Pending CN113694117A (en) | 2021-10-14 | 2021-10-14 | Preparation process of traditional Chinese medicine extract for treating prostate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113694117A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742903A (en) * | 2005-09-29 | 2006-03-08 | 济南宏济堂制药有限责任公司 | Medicine for treating prostatitis and hyperlasia of prostate |
| CN101015609A (en) * | 2007-03-01 | 2007-08-15 | 济南宏济堂制药有限责任公司 | Application of medicinal composition in preparing medicine for preventing and treating male infertility |
-
2021
- 2021-10-14 CN CN202111200188.0A patent/CN113694117A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1742903A (en) * | 2005-09-29 | 2006-03-08 | 济南宏济堂制药有限责任公司 | Medicine for treating prostatitis and hyperlasia of prostate |
| CN101015609A (en) * | 2007-03-01 | 2007-08-15 | 济南宏济堂制药有限责任公司 | Application of medicinal composition in preparing medicine for preventing and treating male infertility |
Non-Patent Citations (4)
| Title |
|---|
| 容小翔: "中西医聚焦慢性前列腺炎", 《开卷有益.求医问药》 * |
| 李景宏: "中西医结合治疗慢性前列腺炎42例体会", 《基层医学论坛》 * |
| 王小虎等: "前列腺汤治疗慢性前列腺炎54例疗效分析", 《新中医》 * |
| 程爵棠: "《男科病证治妙方》", 31 August 2019, 河南科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
| CN102579912B (en) | Chinese medicinal capsules special for treating acute mastitis and preparation method thereof | |
| CN102626505B (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN108853277A (en) | A kind of Traditional Chinese medicine disinfectant for acupuncture | |
| CN113694117A (en) | Preparation process of traditional Chinese medicine extract for treating prostate | |
| CN115364167A (en) | Traditional Chinese medicine oral liquid for treating cow mastitis and preparation method thereof | |
| CN102940738B (en) | Traditional Chinese medicine composition for conducting fumigation-washing treatment for anal pendant expansion after hemorrhoid-fistula operations | |
| CN113230336A (en) | Traditional Chinese medicine plaster for treating shoulder, neck, waist and leg pain | |
| CN107638478B (en) | Yao medicine external preparation for treating skin diseases and preparation method thereof | |
| CN110772623A (en) | Traditional Chinese medicine for treating prostate | |
| CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN110101717A (en) | A kind of outer wound medicine and preparation method thereof containing badger fat | |
| CN103405589A (en) | Traditional Chinese medicine composition for treating cow mastitis and preparation method thereof | |
| CN102688456B (en) | Chinese medicinal composition for treating chronic prostatitis | |
| CN105395765A (en) | External application traditional Chinese medicine preparation for treating chronic nasosinusitis | |
| CN106581555A (en) | Yao medicine composition for treatment of exogenous fever, preparation method and application thereof | |
| CN117064753A (en) | Manufacturing device and manufacturing method of cow mastitis medicament | |
| CN105770538A (en) | Traditional Chinese medicine for treating local vascular access induration of hemodialysis patients | |
| CN105998542A (en) | Traditional Chinese medicine spray for treating acute laryngopharyngitis and preparation method of traditional Chinese medicine spray | |
| CN104383331A (en) | Mulberry-leaf and white-chrysanthemum Chinese medicinal wine | |
| CN104474118A (en) | Traditional Chinese medicine wine for treating exogenous fever | |
| CN104491255A (en) | Traditional Chinese medicine preparation for treating acute cholecystitis | |
| CN105999197A (en) | A traditional Chinese medicine preparation for external use of wormwood for foot soaking for treating qi deficiency and night sweat | |
| CN113144155A (en) | Medicinal liquor for treating pain caused by yin-yang imbalance and preparation method thereof | |
| CN112451606A (en) | Agilawood plaster for promoting blood circulation, removing blood stasis, relieving pain and stopping pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211126 |
|
| RJ01 | Rejection of invention patent application after publication |